Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
+2.48%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$9.11B
AUM Growth
+$193M
(+2.2%)
Cap. Flow
-$282M
Cap. Flow
% of AUM
-3.09%
Top 10 Holdings %
Top 10 Hldgs %
13.71%
Holding
2,165
New
503
Increased
486
Reduced
468
Closed
460
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$152M |
| 2 |
NVIDIA
NVDA
|
+$133M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$129M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
Spirit AeroSystems
SPR
|
+$103M |
Top Sells
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 3 |
UnitedHealth
UNH
|
+$61.9M |
| 4 |
Salesforce
CRM
|
+$60.9M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$58.7M |
Sector Composition
| 1 | Technology | 19.59% |
| 2 | Financials | 11.74% |
| 3 | Industrials | 11.44% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Healthcare | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Gentex
GNTX
$6.13B
| $209K | ﹤0.01% |
+7,029
| New | +$209K |
|
1402
Fidelis Insurance
FIHL
$1.79B
| $209K | ﹤0.01% |
+11,549
| New | +$209K |
|
1403
Indivior
INDV
$3.06B
| $208K | ﹤0.01% |
21,341
+1,341
| +7% | +$13.1K |
|
1404
Boston Omaha
BOC
$419M
| $208K | ﹤0.01% |
13,980
-59,284
| -81% | -$882K |
|
1405
Crane Co
CR
$10.5B
| $208K | ﹤0.01% |
+1,313
| New | +$208K |
|
1406
BCE
BCE
$22.5B
| $204K | ﹤0.01% |
+5,863
| New | +$204K |
|
1407
Full Truck Alliance
YMM
$13.8B
| $202K | ﹤0.01% |
+22,469
| New | +$202K |
|
1408
Tower Semiconductor
TSEM
$7.49B
| $202K | ﹤0.01% |
4,565
-739
| -14% | -$32.7K |
|
1409
UNIFI
UFI
$82.6M
| $202K | ﹤0.01% |
27,511
| – | – |
|
|
VERV
1410
DELISTED
Verve Therapeutics
VERV
| $201K | ﹤0.01% |
41,544
-1,105
| -3% | -$5.35K |
|
1411
Vanguard Long-Term Bond ETF
BLV
$5.7B
| $201K | ﹤0.01% |
2,671
-683
| -20% | -$51.3K |
|
1412
Astronics
ATRO
$1.59B
| $200K | ﹤0.01% |
+10,256
| New | +$200K |
|
1413
Arcutis Biotherapeutics
ARQT
$2.1B
| $195K | ﹤0.01% |
+20,964
| New | +$195K |
|
1414
Forrester Research
FORR
$190M
| $193K | ﹤0.01% |
10,715
-19,378
| -64% | -$349K |
|
1415
Empire State Realty Trust
ESRT
$1.29B
| $189K | ﹤0.01% |
17,099
-26,789
| -61% | -$297K |
|
1416
Akebia Therapeutics
AKBA
$801M
| $188K | ﹤0.01% |
142,274
| – | – |
|
1417
Ardmore Shipping
ASC
$498M
| $186K | ﹤0.01% |
10,251
-138,496
| -93% | -$2.51M |
|
1418
Cantaloupe
CTLP
$795M
| $185K | ﹤0.01% |
25,029
-26,445
| -51% | -$196K |
|
|
LGTY
1419
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $182K | ﹤0.01% |
16,295
-2,046
| -11% | -$22.9K |
|
1420
Petrobras Class A
PBR.A
$74.6B
| $181K | ﹤0.01% |
+13,752
| New | +$181K |
|
|
ORC
1421
Orchid Island Capital
ORC
$954M
| $180K | ﹤0.01% |
+21,940
| New | +$180K |
|
1422
Biomea Fusion
BMEA
$110M
| $180K | ﹤0.01% |
+17,838
| New | +$180K |
|
1423
Codexis
CDXS
$220M
| $179K | ﹤0.01% |
58,093
-41,593
| -42% | -$128K |
|
1424
Acco Brands
ACCO
$355M
| $173K | ﹤0.01% |
31,667
-99,947
| -76% | -$547K |
|
1425
Lyell Immunopharma
LYEL
$257M
| $172K | ﹤0.01% |
6,216
| – | – |
|